[The citrate salt of a pyrazolopyrimidinone derivative structurally related to zaprinast. Sildenafil selectively inhibits cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase, resulting in vasodilation in the corpus cavernosum of the penis and penile erection. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=269137&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=269137&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26670" NCI Thesaurus) ( PDQ )]
UMLS (NCI) C0529793 - Organic Chemical
- Pharmacologic Substance
Relation/PAR: Piperazines
[GU900] GENITOURINARY AGENTS, OTHER
Relation/CHD: Sildenafil Citrate